fincash logo SOLUTIONS
EXPLORE FUNDS
CALCULATORS
LOG IN
SIGN UP

Fincash » Search » Syngene International Ltd

Syngene International Ltd

Updated on September 21, 2020

Stock/Share Code - SYNGENE

Syngene International is engaged in providing contract research and manufacturing services from lead generation to clinical supplies to pharmaceutical and biotechnology companies worldwide. Syngenes s...show more

Below is the details of SYNGENE Syngene International Ltd

Market Cap₹18,968 Cr.
Current Price ₹577.35 as on 25 Sep 20
52 Week High / Low Price₹522 / ₹201.65
Face Value₹10
Stock P/E55.20
Book Value₹54.35
Dividend Yield0.11 %
ROCE16.63 %
ROE17.02 %
Sales Growth (3yrs)18.77 %
SectorPharmaceuticals
IndustryPharmaceuticals - Indian - Bulk Drugs & Formln
Listed onBSE  AND  NSE
Company WebsiteCompany Website
Pros:
Cons: Stock is trading at 8.72 times its book value Promoter holding has decreased over last 3 years: -4.90%

Syngene International Ltd Price Chart

Syngene International Ltd Price Chart

Syngene International Ltd Peer Comparison in Pharmaceuticals

S.No. Name CMP Rs. P/E Mar Cap Rs.Cr. Div Yld % NP Qtr Rs.Cr. Qtr Profit Var % Qtr Sales Var % Sales Qtr Rs.Cr. ROCE %
1. Sun Pharma.Inds. ₹168.25 28.81 ₹124,825.4 Cr. 0.77 -₹1,655.6 Cr. 24.82 -9.42 7585.25 10.53
2. Dr Reddy's Labs ₹5,112.2 36.47 ₹70,902.77 Cr. 0.59 ₹594.6 Cr. -12.11 14.73 4426.50 11.11
3. Cipla ₹770.1 34.95 ₹57,535.92 Cr. 0.42 ₹577.91 Cr. 20.85 8.95 4346.16 11.77
4. Aurobindo Pharma ₹772.1 15.87 ₹47,396.57 Cr. 0.37 ₹780.58 Cr. 20.99 8.82 5924.78 18.73
5. Biocon ₹428 70.21 ₹45,138 Cr. 0.13 ₹149.4 Cr. -27.58 14.56 1671.30 13.11
6. Torrent Pharma. ₹47.5 39.86 ₹45,039.6 Cr. 0.64 ₹321 Cr. 48.61 1.68 2056.00 15.01
7. Cadila Health. ₹385.5 26.88 ₹38,006.44 Cr. 0.94 ₹454 Cr. 49.54 4.11 3639.90 11.83
8. Syngene Intl. 55.20 ₹18,968 Cr. 0.11 ₹57.8 Cr. -19.61 -0.17 420.20 16.63

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Syngene International Ltd Fundamentals

Quarterly Results

Quarterly reports are issued by companies every three months. Most companies have a financial year-end of Mar. 31 and quarters that end on June 30, Sept. 30, Dec. 31 and March 31.

Standalone Figures in Rs. Crores

Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019Mar 2020Jun 2020
Sales -335388409406419467534421465519607420
YOY Sales Growth %10.63%16.74%40.44%39.47%24.88%20.48%30.51%3.67%10.99%11.13%13.75%-0.17%
Expenses -222262280297292327374300326366404296
Material Cost %23.87%27.55%30.70%31.72%26.35%30.53%28.02%25.07%26.93%27.86%23.74%21.35%
Employee Cost %27.95%24.56%24.93%26.01%26.99%24.96%24.39%31.00%28.02%28.90%26.59%32.48%
Operating Profit114126129109126140160121139153204124
OPM %34%33%31%27%30%30%30%29%30%29%34%30%
Other Income161217191817212092202015
Interest5578888781097
Depreciation303534374043444753576266
Profit before tax949810483971061288717010615366
Tax %19%16%19%20%19%19%22%17%25%14%21%12%
Net Profit778284667887100721289212058
EPS in Rs1.942.072.131.661.982.181.261.813.222.313.021.46
NotesNotesNotesNotesNotesNotesNotesNotesNotesNotesNotesNotes

Profit & Loss

The profit and loss (P&L) statement is a financial statement that summarizes the revenues, costs and expenses incurred during a specified period, usually a fiscal quarter or year. The P&L statement is synonymous with the income statement. These records provide information about a company's ability or inability to generate profit" by increasing revenue, reducing costs or both. Some refer to the P&L statement as a statement of profit and loss, income statement, statement of operations, statement of financial results or income, earnings statement or expense statement.

Standalone Figures in Rs. Crores

Mar 2008Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020TTM
Sales -1582673224175507008601,1071,2011,4231,8262,0122,011
Sales Growth %23.29%20.61%29.45%31.99%27.18%22.93%28.74%8.48%18.50%28.28%10.20%
Expenses -1081802232803824855797278169591,2901,3951,391
Material Cost %0.00%25.93%27.34%26.95%26.40%27.36%27.79%28.04%26.80%26.82%29.10%25.82%
Manufacturing Cost %6.88%8.73%8.57%7.20%6.20%5.60%6.90%6.40%7.98%8.17%7.64%7.98%
Employee Cost %23.20%24.95%24.85%23.61%22.47%22.27%23.63%22.64%25.81%26.60%25.60%28.56%
Other Cost %38.47%7.87%8.48%9.34%14.29%14.11%8.99%8.56%7.38%5.78%8.33%6.99%
Operating Profit508799137168214281380385464536617620
OPM %31%33%31%33%31%31%33%34%32%33%29%31%31%
Other Income211248126946275153148
Interest08211060881823323535
Depreciation1645525560668197114131164219238
Profit before tax35352874106157204281346372414516495
Tax %6%12%1%4%4%14%14%14%17%18%20%20%
Net Profit33302771102135175241287305331412397
EPS in Rs57.1151.9646.497.369.7812.913.915.927.187.638.2710.2910.01
Dividend Payout %0%0%0%0%0%0%239%8%7%7%3%0%

Compounded Sales Growth

  • 10 Years:: 22.38%
  • 5 Years:: 18.53%
  • 3 Years:: 18.77%
  • TTM:: 9.27%

Compounded Profit Growth

  • 10 Years:: 27.77%
  • 5 Years:: 15.02%
  • 3 Years:: 7.11%
  • TTM:: 2.09%

Return on Equity

  • 5 Years:: 23.08%
  • 3 Years:: 28.50%
  • 1 Year:: 53.22%

Balance Sheet

A balance sheet is a financial statement that reports a company's assets, liabilities and shareholders' equity at a specific point in time, and provides a basis for computing rates of return and evaluating its capital structure. It is a financial statement that provides a snapshot of what a company owns and owes, as well as the amount invested by shareholders. It is used alongside other important financial statements such as the income statement and statement of cash flows in conducting fundamental analysis or calculating financial ratios.

Standalone Figures in Rs. Crores

Mar 2008Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
Share Capital -333242626199200200200200400
Equity Capital333242626199200200200200400
Reserves1851912182734926336468251,2241,5201,7671,774
Borrowings39200159974155155891806787813773
Other Liabilities -551181241932013774224405446819221,215
Trade Payables1138286483776974102203224223
Advance from Customers1213142232193219238226234268310
Other liability items32688210687107134128216244431683
Total Liabilities2825125045877241,1911,4222,3562,7753,1883,7024,162
Fixed Assets -1424033883833813945035808101,0301,3772,020
Gross Block1804033883833813949381,1111,3321,6612,1713,017
Accumulated Depreciation3800000435531522630794998
CWIP736111945105237175155274234
Investments15113069352146277540158716777
Other Assets -51931131932653996671,2621,2491,8451,3361,132
Inventories796151815383832864325
Trade receivables253338437794180185199267339398
Cash Equivalents176381292116720527966435280
Loans n Advances181225446585111200323361354336
Other asset items-13338529411422211916816516492
Total Assets2825125045877241,1911,4222,3562,7753,1883,7024,162

Cash Flows

Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business. At the most fundamental level, a company’s ability to create value for shareholders is determined by its ability to generate positive cash flows, or more specifically, maximize long-term free cash flow.

Standalone Figures in Rs. Crores

Mar 2008Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
Cash from Operating Activity -47818012210430018308398446630677
Profit from operations517994129159205276374436553543739
Receivables112-6-4-33-20-78-11-19-74-70-36
Inventory3-62-9-33-2416-544318
Payables68-63619-6-12951123223236
Loans Advances-4-1-0-7-4-6-1800000
Other WC items0-40-11-15158-84-24-1-23-13-174
Working capital changes610-96-36129-216-2637-2718245
Direct taxes-10-8-6-12-20-35-42-40-74-81-96-106
Cash from Investing Activity --85-30-18-20-150-37516-753-470-350-646-424
Fixed assets purchased-122-59-29-26-61-100-197-293-306-364-583-643
Fixed assets sold002013000000
Investments purchased-193-343-290-273-339-603-422-982-1,075-945-789-881
Investments sold2283722982752703206288528181,363888912
Interest received0000040041165589
Dividends received21012510614200
Invest in subsidiaries000000000-000
Other investing items0002-24-4-3-33639-422-21698
Cash from Financing Activity -38-45-62-7021155-10716-81-79-72-226
Proceeds from shares0005120013322521
Proceeds from borrowings3900401601873900109106
Repayment of borrowings0-37-42-69-93-4-250-66-37-129-268
Interest paid fin-0-8-21-10-6-0-8-1-18-23-30-35
Dividends paid000000-114-200-24-24-24
Financial liabilities00000000000-4
Other financing items000000-15-4000-1
Net Cash Flow16-132-268024272-15317-8828

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Ratios

Mar 2008Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
ROCE %19%13%22%25%23%23%20%18%16%17%17%
Debtor Days594544385149766160686872
Inventory Turnover0.8814.3112.4410.1513.1010.008.9710.087.058.8516.48

Announcements & News

Recent Announcements

How to Invest in Mutual Funds SIP Online?

  1. Open Free Investment Account for Lifetime at Fincash.com.
  2. Complete your Registration and KYC Process
  3. Upload Documents (PAN, Aadhaar, etc.). And, You are Ready to Invest! Get Started
  4. Invest in Mutual Funds which invests in Syngene International Ltd & Get More Returns than Bank Deposit

Disclaimer:
All efforts have been made to ensure the information provided here is accurate as per time to time filling by company to exchanges. However, no guarantees are made regarding correctness of data. Investors are advised to validate/check information with exchanges or companies website before making any investment decisions.